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Background: Conducting clinical trials with pre-term or sick infants is important if care for this population is to be
underpinned by sound evidence. Yet approaching parents at this difficult time raises challenges for the obtaining
of valid informed consent to such research. This study asked: what light does the empirical literature cast on an
ethically defensible approach to the obtaining of informed consent in perinatal clinical trials?
Methods: A systematic search identified 49 studies. Analysis began by applying philosophical frameworks which
were then refined in light of the concepts emerging from empirical studies to present a coherent picture of a
broad literature.
Results: Between them, studies addressed the attitudes of both parents and clinicians concerning consent in
neonatal trials; the validity of the consent process in the neonatal research context; and different possible methods
of obtaining consent.
Conclusions: Despite a variety of opinions among parents and clinicians there is a strongly and widely held view
that it is important that parents do give or decline consent for neonatal participation in trials. However, none of the
range of existing consent processes reviewed by the research is satisfactory.
A significant gap is evaluation of the widespread practice of emergency ‘assent’, in which parents assent or refuse
their baby’s participation as best they can during the emergency and later give full consent to ongoing
participation and follow-up. Emergency assent has not been evaluated for its acceptability, how such a process
would deal with bad outcomes such as neonatal death between assent and consent, or the extent to which late
parental refusal might bias results.
This review of a large number of empirical papers, while not making fundamental changes, has refined and
developed the conceptual framework from philosophy for examining informed consent in this context.
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The recruitment of pre-term or sick infants to clinical
trials requires approaching parents at a particularly diffi-
cult time, often within a tight timescale for making a de-
cision. This raises challenges for the obtaining of valid
informed consent to such research. But given the im-
portance that has been attached by codes of ethics to
gaining informed consent for medical research, if the
problem of consent cannot be successfully addressed,
there is a risk of this becoming an ‘orphan’ area of
research.
This paper reports on research examining and ad-
dressing these difficulties. We undertook this systematic
review of the empirical studies on these ethical chal-
lenges within the context of a larger project focused on
improving care for the pre-term infant (with a special
focus on the timing of cord-clamping).1
This is the first such review focusing on the ethical is-
sues around consent to neonatal research. There have
been other reviews which have focused on methods of
increasing recruitment or of improving the means of
conveying information, for example, but none that have
focused directly on the ethical issues [1–6]. Our overall
aim in conducting the review is to identify a way of
mounting ethical neonatal research in those circum-
stances where obtaining valid consent from parents has
proved a significant challenge. This is important since if
research cannot be conducted ethically it will not be
possible to provide a research service for this
population.
Thus, this review aims to synthesise observational
and qualitative studies that explore the process of
consent to such trials, and report parents’ and clini-
cians’ views and experiences. The goal is to identify
both the challenges to an ethically defensible consent
process, and potential solutions, in order that ethical
research can continue to be mounted in this area.
This approach to addressing problems in medical
ethics is methodologically rather novel. In this case
the research has been undertaken by a multi-
disciplinary team with background expertise in phil-
osophy, clinical practice, social science, information
science and advocacy for parents, all of whom have
brought complementary skills to the task. For the
philosophers, the methods involved in systematic re-
view were somewhat different from those that are
conventionally adopted in work on ethics. The notion
of a systematic review is very uncommon, indeed al-
most unknown, as a method for conducting research
in philosophy, both in philosophy as a whole and in
philosophical medical ethics in particular [7–9].
On the other hand, for the social scientists and clini-
cians the standard philosophical means for resolving eth-
ical problems were unconventional by the standards oftheir disciplines. As a result the whole process of devel-
oping a systematic review in ethics through inter-
disciplinary collaboration has given rise to considerable
reflection in its own right. These unpublished observa-
tions of authors of this paper are being collated. How-
ever, for the purposes of this paper the method used in
developing a systematic review will be described without
significant space being given to detailed further reflec-
tion on that process.
The paper begins by setting out the method by
which this systematic review was undertaken, then
gives an account of the results, and concludes with a
discussion of some of the key points arising from the
results.Methods/Design
Our overarching question was: what light does the
empirical literature cast on an ethically defensible ap-
proach to the obtaining of informed consent in peri-
natal clinical trials?
In broad outline the method adopted for this review
conformed to that set out for a framework synthesis
in Gough, Oliver and Thomas’s recent account of sys-
tematic reviews [10]. The first stage was the develop-
ment of a tentative initial conceptual framework2
which relied mainly on prior knowledge of the exist-
ing philosophical literature on informed consent
(prominent books and papers). This included know-
ledge of material that was more specifically focused
on the difficulties of gaining informed consent in neo-
natal trials (in particular the Euricon study) [11, 12].
This initial conceptual framework informed the cri-
teria for including studies.
An initial search of two databases of research literature
(one medical and one philosophical) was then under-
taken by an information specialist based on this tentative
conceptual framework. The framework was then refined
in light of the literature uncovered by the initial searches
(stage 2 in Gough, Oliver and Thomas’ account, [10]),
and the search strategy amended accordingly before be-
ing applied in full to a broader range of databases. At
stage 3 the task of coding articles was undertaken, and
this led to stage 4, the tabulating of the data. The final
stage was then drawing conclusions from the tabulated
data (stage 5).Methods
The aim of the search was to identify studies for a re-
view of ethical issues around consent that arise from the
involvement of either pre-term babies or sick neonates
in clinical trials.
Articles potentially eligible for inclusion were those:
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commentary concerning;
 Consent, participation or recruitment for
neonatal research (relevant to clinical trials)
 Parental decision-making for treatment of, or
research with, sick or pre-term neonates
 Parental decision making for birth/labour
 Methodology in emergency/urgent neonatal
research
 Alternative ways of gaining consent for neonatal
research
ii). with full text available in English
As this focus raises issues that have previously been
studied by multiple academic disciplines (e.g. obstetrics,
fetal-maternal medicine, neonatology, social science, bio-
ethics) a range of database sources were searched (see
Additional file 1). Briefly, literature emerging from the
draft searches using MEDLINE and Philosopher’s Index
helped to develop the tentative conceptual framework
further.
Titles and abstracts, and subsequently full texts,
were retained only if they matched the inclusion cri-
teria. Articles were screened by a researcher with
clinical and ethics expertise (EW) who adopted an
over-inclusive approach to avoid losing any relevant
studies; when in any doubt the decision was discussed
with a philosopher (CM).
The ‘included’ articles were then separated into ‘empir-
ical’ (quantitative or qualitative research) and ‘analytical’
(philosophical discussion or commentary). The ‘empir-
ical’ papers which were identified as potentially relevant
after the screening process were re-read to identify re-
current themes. The themes that emerged were:
i). Attitudes of clinicians to parental consent
ii). Assessing the quality of consent
iii).Different methods of seeking and gaining consent
iv).Attitudes of parents and clinicians to neonatal trials
v). Best interests versus consent
vi).Antenatal counselling practices
vii).Clinical uncertainty
viii).Information transmission
ix).Perception of who has made the decision
Draft summaries of each theme were distributed to the
steering group which comprised a social scientist, another
clinician, a parents’ representative and the information spe-
cialist. After discussion with the steering group, the concep-
tual framework was modified to focus on the specific
questions prioritised by the steering group. As a result,
more focussed inclusion criteria were then set for the em-
pirical papers, based on the modified conceptual frame-
work. Articles finally eligible for inclusion were those:i). reporting any empirical research or analysis/
commentary concerning:
 Parents’ views of neonatal trials
 Clinicians’ views of neonatal trials
 Parents’ and clinicians’ views of parental consent/
decision-making in clinical practice IF the articles
concerned the validity of the consent in an
emergency situation or during or soon after
labour
 Validity of consent
 Other options for gaining consent
ii). with full text available in English
Further searches were devised with attention to the
amended framework, terms suggested by the project team,
database index terms, and recent literature listing terms
useful in retrieving bioethics studies [8, 9, 13]. Additional
file 1 shows an example search strategy. Additional data-
bases were chosen to search based on their availability and
the advice offered in the literature on bioethics studies re-
trieval, [8, 9, 13, 14].
The results of the further searches were then consid-
ered. Papers from these references were screened, and ‘in-
cluded’ or ‘excluded’, based on abstracts using the second
set of five inclusion criteria set out above. However, on
this second screening addressing a focused review ques-
tion allowed the review team to apply the concept of data
saturation to the task of seeking additional studies [15]
and demanded, in addition, very definite positive reasons
to include further papers. There had to be clear indica-
tions that some new insights were being added to those
we already had from the initial set of papers. In effect the
approach here was analogous to treating research findings
as saturated. Update searches were conducted on all previ-
ously chosen databases and subject to the same screening
methods.
Results and discussion
The PRISMA diagram (Additional file 2) illustrates the
flow of studies throughout the review. The searches
identified 1361 records (234 from the first searches, 790
from the second round, 327 from the update searches).
A set of 41 papers identified from MEDLINE and Phi-
losopher’s Index met the original inclusion criteria.
Expanding the databases and introducing new search
terms while narrowing the scope led to a total of 49 em-
pirical papers being ‘included’.
Table 1 sets out the research context for these in-
cluded studies.
The next stage (stage 3) was for the findings of these
included empirical papers to be coded according to
themes generated from the modified conceptual
framework.
Table 2 presents the themes covered in this coding.
Table 1 The context for the included studies
Context of study Reviews Questionnaires/Surveys In-depth interviews Miscellaneous
Emergency perinatal
research
Hundley 2004
[56]
East 2006 [49] Baker 2005 [24]
Tooher 2008
[30]
Kenyon 2004 [50] Kenyon 2004 [50]
Smyth 2009 [22] Smyth 2012 [23]
Snowdon 2006 [28]
Emergency neonatal
research
Ballard 2004 [46] Allmark 2006 [47] Schmidt 1999 (observation of outcomes)
[57]
Burgess 2003 [25] Mason 2000 [34]
Culbert 2005 [53] Snowdon 1997 [48]
Maayan-Metzger 2008
[19]
Snowdon 1998 [33]
Stenson 2004 [35]
Zupancic 1997 [21]
Research during pregnancy Daniels 2006 [52] Mohanna 1999 [58]
Woodward 2012 [54]
Non-emergency neonatal
research
Ballard 2011 [51] Hoehn 2009 [32] Hoehn 2005 (analysis of unsolicited
comments) [17]
Burgess 2003 [25] Jollye 2009 [18] Hulst 2005 (observational study) [31]
Hayman 2001 [16] Korotchikova 2010 [29]
Marc-Aurele 2012 [45] Rogers 1998 [55]
Morley 2005 [20] Simon 2006 [60]
Nathan 2010 [59] Snowdon 1998 [33]
Singhal 2002 [26] Snowdon 2004 [42]
Singhal 2004 [41] Snowdon 2004 [39] Ward 2009
[27]
Clinical decision-making (not
research)
Paulmichl 2011 [43] Albersheim 2010 [40] Sharma 2011 (analysis of decisions
made by mothers) [64]
Brinchmann 2002 [36]
De Leeuw 2000 [61]
Garel 2004 [62]
Kavanaugh 2005 [37]
McHaffie 2001 [38]
Saigal 1999 [63]
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coding made it possible to tabulate the coded papers
against the themes (tabulation of the results, stage 4). In
effect this tabulation provides a summative identification
of the key ethical points made in the papers analysed.
The full findings are presented in Additional file 3. The
findings discussed in this ‘results’ section are those
which contributed to the broader theme particularly
relevant to our research question.
In what follows, first of all we will present these tabu-
lated results in prose form, and then in the last section
we will discuss the conclusions to be drawn concerning
the ethically significant features of those results. It
should be noted that in tabulating the results we did not
attempt to ‘weight’ the contribution of a paper to atheme according to the size or quality of the study,
though the social scientist evaluated the papers and
found them all of sufficient quality to be included.
Additional file 4 presents a table of all the empirical
studies included in the review and their quality evaluation.
All of the studies included at this stage met the quality as-
sessment criteria.3
a) Attitudes of parents concerning consent in neonatal
trials
The empirical papers which explored ‘the attitudes of
parents’ to consent in the process of research involving
neonates covered a wide range of considerations of
interest from the point of view of our research question,
Table 2 The themes covered in the coding of the included papers
Themes covered Reviews Questionnaires/surveys In-depth interviews Miscellaneous
Attitudes of parents Tooher 2008 [30] Burgess 2003 [25] Baker 2005 [24] Hoehn 2005 [17]
Hayman 2001 [16] Brinchmann 2002 [36]
Maayan-Metzger 2008 [19] Hoehn 2009 [32]
Morley 2005 [20] Hulst 2005 [31]
Paulmichl 2011 [43] Jollye 2009 [18]
Singhal 2002 [26] Kavanaugh 2005 [37]
Smyth 2009 [22] Kenyon 2004 [50]
Stenson 2004 [35] Korotchikova 2010 [29],
Zupancic 1997 [21] Mason 2000 [34]
McHaffie 2001 [38]
Smyth 2012 [23]
Snowdon 1998 [33]
Snowdon 2004 [39]
Snowdon 2006 [28]
Ward 2009 [27]
Attitudes of clinicians Paulmichl 2011 [43] Albersheim 2010 [40]
Singhal 2004 [41] De Leeuw 2000 [61]
Garel 2004 [62]
Garel 2011 [44]
McHaffie 2001 [38]
Snowdon 2004 [42]
Validity of consent Tooher 2008 [30] Ballard 2004 [46] Allmark 2006 [47]
Ballard 2011 [51] Hoehn 2005 [17]
Burgess 2003 [25] Hoehn 2009 [32]
Daniels 2006 [52] Jollye 2009 [18]
East 2006 [49] Kenyon 2004 [50]
Hayman 2001 [16] Mason 2000 [34]
Kenyon 2004 [50] Smyth 2012 [23]
Marc-Aurele 2012 [45] Snowdon 1997 [48]
Nathan 2010 [59] Snowdon 2006 [28]
Smyth 2009 [22] Ward 2009 [27]
Stenson 2004 [35]
Different consent processes Hundley 2004 [56] Ballard 2004 [46] Allmark 2006 [47]
Ballard 2011 [51] Hoehn 2009 [32]
Culbert 2005 [53] Mohanna 1999 [58]
East 2006 [49] Rogers 1998 [55]
Woodward 2012 [54] Smyth 2012 [23]
Miscellaneous topics Rogers 1998 [55] Schmidt 1999 [57]
Saigal 1999 [63] Sharma 2011 [64]
Simon 2006 [60]
Snowdon 1998 [33]
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to research participation, or for declining; and their
views and feelings about the research itself.
Motivations of parents for consenting or declining to
participate in research
There is consistency across multiple studies regarding
the stated motivations for parents to consent or decline
to participate in perinatal or neonatal trials. In favour of
participation there was, on the one hand, ‘altruistic’ mo-
tivation4 – the benefit that entering the trial might bring
to other babies, parents, doctors, or to society/science
[16–24]. On the other hand, parents were motivated by
the possibility of some benefit to their baby himself5 [17,
20, 25–27, 21, 23], or to the mother [23] – or the trial’s
bringing some hope in a hopeless situation [28].
By contrast, parents also reported their motivations
for declining to participate in research. There was the
inconvenience for the parents [16, 29, 23, 30], but also
the burden for their child [31, 24], whilst another con-
sideration was worries about the risks involved, with
concerns about the risks to their baby dominating those
about risk to the mother [16–19, 26, 21, 22, 24, 30]. Fi-
nally, some felt that they did not have enough time to
decide [32, 18]. However, it is reported that the severity
of the illness of the infant did not affect trial participa-
tion [31, 18].
Parental emotions regarding child’s participation in
research
There are also a number of consistently reported feelings
or emotions from parents about the medical/emergency
context making them eligible to be approached for re-
search. Thus, there were experiences of fear or dread
[18, 28, 27, 23, 30], of confusion [18, 27, 23, 28], and of
vulnerability [27, 24]. Other emotional responses were
indirectly relevant to parental decision-making in that
they reflected parental feelings after the decision had
been made. These included: pride in having participated
in the trial [18, 33, 23, 24]; although guilt after enrolling
their child was also reported [18]. Another facet covered
by the empirical research is the attitudes that parents
take to the whole process of decision-making or con-
senting for trials. There are a number of findings here.
Parental views on the process of deciding to consent or
decline
First, parents feel that a formal consent form is neces-
sary for research, and that this is necessary in order to
protect their child [25]. Most parents also feel they
ought to make the decision about whether their child
participates in research [25, 34, 20, 26, 35], and reported
reasons for this are similar across several studies. Thus,
parents want to feel involved or informed about theirchild, and to maintain some control over what happens
to him [36, 37, 28, 27]. A second reason is that it is part
of the parents’ role or responsibility to take decisions of
this sort [28, 27]. And this second reason is itself then
grounded either in the unique relationship that parents
have with their child [36] or in the fact that the parents
must live with the outcomes of the decision [36]. Parents
also feel they ought to take the decision in order to pro-
tect their baby from risk [18, 26, 24].
However many parents also wanted input from others
as well before making the decision. This might include
support from their spouse or wider family [32, 18, 29,
28, 23]. But they also noted the importance of a discus-
sion with their doctor [32, 38, 28], either because they
felt they lacked sufficient skills or knowledge to make
the decision on their own [36], or because they put their
trust in doctors to recommend the right decision [18,
23]. On the other hand some parents did not want to
make the decision [36, 18, 21, 24].
In this connection there was a frequent finding that
parents felt that being approached about a trial added to
their stress and anxiety at a difficult time [36, 18, 35, 21,
23, 24], although this was not universal; two studies
found parents reporting no extra burden [39, 35]. Par-
ents also reported that the burden of decision-making
increased if they were approached at an inappropriate
time [23, 22, 24, 30].6
b) Attitudes of clinicians concerning consent in neonatal
trials
Empirical research has also examined the attitudes of
clinicians to the consent process and these studies make
for an interesting comparison with the work on parents’
attitudes, which we will comment on in the concluding
discussion. The views of clinicians covered a range of
topics which overlapped with those on which parents
commented but also covered issues going beyond those
discussed by parents.
A major area of overlap concerns the attitudes that cli-
nicians take to parental participation in the process of
decision-making, or in consenting for research.
Clinician views concerning parental participation in the
consent process
Clinicians reported they respect parental authority [40]
and for the most part clinicians feel that parental in-
formed consent is necessary for trials [41, 42]. In justify-
ing this, clinicians give a number of reasons for allowing
parents to make the decision. First, there is respect for
‘parental rights’ [40] which might be seen simply as an
elaboration of the notion of respect for parental author-
ity. Then there is the claim that parents are best placed
to act in the best interests of their child [40, 43, 41], and
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long-term outcomes of their decisions [40].
On the other hand some clinicians were more sceptical
about the overriding importance of respecting parental
authority. Thus some felt that clinicians are the best
decision-makers for sick babies [43]. Along the same lines,
in some studies clinicians reported prioritising their own
idea of infant best interests over parental autonomy [40].
Some clinicians reached a closely related conclusion in
virtue of wanting to spare parents the burden of making
decisions [38, 44]. Similarly some reported involving par-
ents by trying to ‘convince’ them of the need to consent
[44]. However, some clinicians feel decisions should be
made jointly [40]. In this context of reflecting on the
role of clinicians and parents in decision-making, one
study reported clinicians as seeing a conflict between in-
fant best interests as a basis for parental decision-
making and infant best interests as a limitation to paren-
tal authority [40].
Clinician views on the effect of seeking consent on trial
participation
Some clinicians are concerned that trial participation is
dropping due to problems with obtaining consent [42].
On the other hand there was equal concern that parents
could be pressured to participate [42] .
Clinician views on the consent process
Studies also reported clinicians’ views on consent forms
and communication. Thus, clinicians suggested two pos-
sibilities as to reasons for having consent forms and: that
the forms are provided in order to protect researchers
(by providing confirmation that information was given);
and that they are there to aid communication with par-
ents and improve their understanding [42]. However, cli-
nicians also worried that too much information adds to
the burden for parents who are already facing difficult
circumstance [42]. In the same vein clinicians noted bar-
riers to effective communication; namely, intimidation
of parents [43], lack of care and support for them [43],
failing to keep promises or raising false hopes [43], and
caregivers presenting parents with diverging proposi-
tions about the research [43].
Finally, the empirical studies have reported on clin-
ician views in two further slightly more theoretical areas
concerning consent for research. Clinicians raised con-
cerns about balancing their responsibility to the trial
they were seeking to conduct with their responsibilities
to the parents. Some took the view that these were
‘equal responsibilities’ – and that it is possible to dis-
charge both responsibilities satisfactorily [42]. Others
saw the possibility of ‘divided responsibilities’ – a pos-
sible conflict of interests, causing anxiety to clinicians
[42] or of the need for ‘prioritised responsibility’ – inwhich clinicians must put parents’ interests before the
interest of the trial [42].
c) The validity of the consent process in the neonatal
research context
Mason and Allmark found that only 59 % of parents
giving consent for neonatal trials had given valid consent
according to self-reported problems with consent, in
terms of either voluntariness, competence, or informed-
ness (grasp of relevant information). This was based on
a thematic analysis of interviews, and a subgroup ana-
lysis showed that this problem was even greater when
parents were giving consent for urgent or emergency re-
search [34].7
The analysis of the empirical papers revealed further
views about the voluntary or coerced nature of the con-
sent process, the extent to which parents were informed,
and their competence or capacity to understand the
information.8
i) Voluntariness and coercion or pressure
Some parents reported feeling pressure to participate
[25, 16, 22], but others reported feeling no pressure [25,
17, 35]. Some parents knew they had the right to refuse
to participate [25, 22, 45], but some did not [46]. Some
demonstrated voluntary consent (according to some spe-
cific measure by the researcher) [47].
ii) Competence or capacity, and understanding
The competence, or capacity, of parents to give valid con-
sent is potentially affected by a number of factors including
emotional state, degree of understanding achieved and time
available to decide. Studies covered all these factors. In
terms of their emotional condition, in one study some par-
ents reported they were calm when they made the decision
[25], but others felt they had been anxious or stressed [25].
In some studies parents reported not making a proper deci-
sion [48, 28] due to pain [22], or due to anxiety and desper-
ation. However, in others parents reported making
considered and active decisions [25] despite pain [27], or
time pressure [32] or anxiety and desperation [47, 28].
So far as understanding was concerned, some parents
reported clear understanding of a trial [25, 48, 35, 49]
and some parents demonstrated clear understanding of
a trial (according to some specific measure) [18, 45, 47].
However, some parents reported problems with under-
standing a trial about which they were asked for consent
[32, 34, 23, 22], and some parents demonstrated little or
no understanding of such a trial (according to some spe-
cific measure) [46, 25, 50]. Some parents felt they could
isolate a ‘critical factor’ to make a genuine decision even
with suboptimal understanding [28]. Some parents
showed that they had not understood risks correctly
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risks) [46, 51, 28]. Some showed deficiency in under-
standing trial methodology [30, 45] and it was reported
that the communication skills of the clinician affects un-
derstanding, and could sometimes be deficient in some
ways [43, 23].
Time might be a factor which can affect capacity or
competence in a particular situation because of its bear-
ing on the ability, in the circumstances, to process infor-
mation. Two studies (each concerning more than one
trial with different timescales and different levels of risk)
found that while the majority of parents felt they had ad-
equate time, in the circumstances, to make the decision
a significant minority did not [25, 32]. In this context,
some studies found that parents made rapid decisions
regardless of how much time was actually available [28].
On the other hand, others found parents needed more
time the greater the risk [28]. Furthermore, other studies
found that with non-urgent trials there was a gradual
understanding and acceptance of information over time
[18].
iii) Information
In order to give valid consent, parents must receive the
relevant information. Some parents reported receiving
satisfactory information [25, 35, 52, 49, 45], and some
parents demonstrated having satisfactory information
(according to some specific measure) [47]. However,
some parents reported problems with the information
they were given, or an unsatisfactory level of information
[34, 22]. In particular the information sheet is intended
to play a significant role here, but was found often to be
unread [34]. But in some studies parents remembered
being given an information sheet [18, 35, 23, 50], and
parents used the information sheet when making the de-
cision [18, 23 (less than half ), 50]. With respect to an-
other important consideration, some parents reported
having no opportunity to ask questions [25], but other
parents in the same study remembered having the op-
portunity to ask questions [25].
d) Different methods of obtaining consent
Empirical studies have explored parental attitudes (but
not, it seems, clinician attitudes) to various methods of
obtaining valid consent which have been proposed in
the literature or trialled. In general, mothers acknow-
ledge the difficulties for researchers in finding the ‘right
time’ to approach them for consent for perinatal re-
search [23].
i) Antenatal consent
It was found that some parents would prefer ante-
natal consent rather than consent during, or after,labour [53, 32, 54, 23], and it was found that parents
would like the information earlier in pregnancy even
if they were not recruited then. However, it was also
found that parents were not completely comfortable
with antenatal consent [53, 32]. Thus, parents re-
ported not seeing the relevance of the trial at the
time of antenatal consent – ‘it will never happen to
me’, and also reported increased burden or anxiety if
told about the trial earlier in pregnancy [23].
ii) Consent in labour
Iit was found that some parents were comfortable with
consent in labour [23], although this is a burden on staff
at a busy time [49], but that some parents were not
comfortable with consent in labour [53, 23].
iii) Waived consent
It was found that parents were not comfortable with
waived consent [53].
iv) Opting out
In this method consent is presumed unless the parent
explicitly opts out of the trial as opposed to conventional
consent when the parent has to positively choose to
enter the child (and this was examined for a case when
both were done antenatally): it was found that some par-
ents were comfortable with opting out [55], but also that
some parents were not comfortable with opting out [53].
In addition, more parents were recruited via the opt-out
method [55] and understanding was reported as better
in opt-out consent [55], but the opt-out consent method
did not reduce the burden on parents [55].
v) Continuous consent
In this approach, advocated by Allmark and Mason
[40], there is initial agreement to participate, but then
continuing discussion and further information after
recruitment.) It was found that the validity of the
consent improves when discussion continues after re-
cruitment (presumably this refers to the validity of
the later ‘continued’ consent not of the original con-
sent, whose validity cannot be changed by later
events) [47, 46]. Some parents approve of continuous
consent [47], but some parents have concerns about
continuous consent – concerns about receiving fur-
ther information at a later stage when that might
have affected their original decision [47].
vi) Staged consent process
An empirical study has reported on a staged consent
process in which consent (oral or written) is sought
antenatally, and the consent is sought again at the point
of intervention. However, at present this is only reported
not discussed [56].9
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Where parents received standard counselling plus add-
itional material including a one-page summary of the
trial and a set of frequently asked questions, this was
found (by researchers) to result in better understanding
than conventional consent, but still to leave significant
gaps in understanding for most parents [51].
Conclusions10
Our main aim in conducting this review has been to
establish an ethically acceptable way for conducting
neonatal research. In that context the main conclu-
sions are that:
1. There is widely held agreement that it is important
that parents do give or decline consent for neonatal
participation in trials; but that
2. There is evidence that existing consent procedures
are unsatisfactory; and that
3. None of the proposed alternative consent processes
reviewed by the research is satisfactory; and
4. There are some significant gaps in the empirical
research in this area.
Parental and clinician attitudes
Agreement on the need for parental consent
A key conclusion is that although parents and clinicians
are quite divided about a number of issues regarding the
consent process, there is almost universal agreement
about the importance of parents giving (or declining) con-
sent for neonatal participation. This is very important be-
cause one possible response to the difficulty of conducting
neonatal research ethically is to suggest that in this area
the requirement for informed consent should be dropped.
This research strongly rebuts that proposal.
Despite the variety of views, the studies reveal that
parents very generally see it as important that parents
give consent to (or decline) their child’s participation in
trials, and they have several good reasons for this.11
However, they may not be fully aware of the challenges
to giving valid consent to research. Likewise, clinicians
too do have reasons for respecting parental authority
(though not always for exactly the same reasons, and it
is interesting what reasons they agree upon and that
they disagree about, according to the data).
Furthermore, clinicians, as well as parents, can view
the problem not just in terms of consent but in terms of
the child’s best interests, and in terms of the value of re-
search. And although parents generally wish to make the
decision, often they desire advice from doctors, recognis-
ing their skills and experience.
The results also show how, in the complexities of ac-
tual practice, the very same events in a process can both
be seen in different ways (as the data suggests) and slidefrom being one kind of act into being a different kind.
So seeking advice (parental view) and giving advice to
inform a decision (clinical view) might be, or become,
seeking direction (parental view) and giving a very defin-
ite steer (clinical view), which might be, or become, the
parent not wishing to decide (parental view) and the
clinician relieving the parent of the ‘burden’ of decision-
making (clinician view).
This last point might be taken as evidence that seeking
parental consent is not necessary. But, to reiterate our
conclusion, the results show clearly that there is wide
agreement (amongst most parents and clinicians) that it
is important that parents do give or decline consent for
neonatal participation. And thus there is a need to find a
suitable process.
Divergent parental and clinician perspectives
Clearly parents and clinicians approach the issues exam-
ined in empirical research from different perspectives:
on the one hand (parents) as potential or actual givers of
consent (or decliners) for participation in a neonatal
trial; on the other hand (clinicians) as researchers re-
sponsible for delivering important research, but often
also as carers with responsibility for the best interests of
the neonate (and possibly also the mother, in the case of
fetal-maternal research). This means that the focus of
empirical research covers some questions which only
really apply from the parental perspective, but others
which apply only from the perspective of a clinician/re-
searcher. However, there is a third area where questions
addressed to clinicians and parents intersect.
Difficulties in giving valid informed consent
Research which focused primarily on parents covered
matters such as their emotional state and their under-
standing of information and, although views were not
uniform, confirmed that there are difficulties for at least
some parents in both areas, from the point of view of
giving valid consent. With respect to the clinical per-
spective the studies revealed both clinical concerns that
neonatal research participation is dropping due to prob-
lems with consent, and also the ethical difficulties that
clinicians face in discharging conflicting duties to re-
search, neonates, and parents.
Perhaps the most interesting area covered by the stud-
ies is that where parental and clinical responses inter-
sect, for the results here bring out forcefully the rather
messy nature of practical attempts to address the ethical
issues around consent for research in circumstances
(such as perinatal) where gaining valid consent is diffi-
cult. This is both reflected in and partly explains the var-
iety of views represented in the research. And one might
add that where there are clashes in view, that might also
be partly explained by the fact the parents tend to see
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sponsibility to children, and b) their limited experience
of the challenges in giving valid consent in these circum-
stances, whilst clinicians naturally also view it from c)
the point of view of a clinical responsibility for patient
interests, but also d) that of a researcher worried about
the challenge of getting real consent and e) that of a re-
searcher concerned to take forward good research in this
area and to avoid it becoming an ‘orphan’ research area.
Validity of consent and modes of consent process
The second main conclusion is that existing consent
processes do not lead reliably to valid parental consent,
and the third that there is an urgent need to find an ef-
fective procedure.
Parents fail to give valid consent
Although there is a division of parental opinion, the
studies show conclusively that enough parents have
failed to give valid consent (measured against one or
other of the three criteria of validity – voluntariness,
informedness and competence) to suggest that concerns
about current efforts to obtain parental consent to neo-
natal participation in perinatal research are warranted.
Alternative methods of gaining consent are not satisfactory
Our third concluding point coheres with this. It is that
the studies discussed in the fourth section of results
above confirm that, even on empirical grounds, none of
the varied processes adopted in order to obtain valid in-
formed consent in neonatal trials are working suffi-
ciently well. Although some parents are ‘comfortable’
with each method, other parents are not. It is very likely
that this is because, for all the methods considered, valid
consent is not being achieved for some parents.12
Taking these three main points together, it follows,
then, that there is that a need for a suitable consent
process for neonatal trials, but that none of the proce-
dures examined in the empirical studies to date look to
be adequate. So there is a need for another process.
Now, for urgent and emergency research there is in
fact a distinct possible consent process, described below.
However, our fourth conclusion is that the empirical
studies do not as yet provide any data on attempts to
implement this procedure. So we now turn to this im-
portant point.
Gaps in the empirical literature
Although large, our search has nonetheless identified
important gaps in the empirical literature relevant to
consent for perinatal trials.
The first gap is the most important with respect to the
goal of finding an ethically acceptable way to conduct
neonatal research. This is the lack of any study on a newprocess for obtaining urgent or emergency consent in
perinatal research where there is very little time in which
to seek consent to participation. There do not seem to
be any empirical studies of such a process. This process
involves seeking ‘assent’ to participation in the trial from
parents at the outset, accepting that there is insufficient
information for fully-informed consent at that point, but
then providing further information over time which al-
lows the parents to give full consent (or an informed
withdrawal), which is different in kind from the assent
sought at the outset.13 Such a process may make ethic-
ally acceptable neonatal research possible in urgent/
emergency situations so empirical work on its effective-
ness is a significant gap to fill.
A second gap concerns empirical studies on fetal-
maternal research, that is trials in which both the
mother and the fetus or neonate are participants and
thus in which both fetal/neonatal interests and maternal
interests are in question. Our review did not uncover
studies that considered consent for research in this
context.
Finally, a third gap concerns empirical studies which
report the views of bereaved parents on the consent
process. Up till now empirical studies have almost com-
pletely excluded views of parents whose sick child par-
ticipated in research and survived.14
Endnotes
1NIHR Programme in Applied Health Research, Im-
proving quality of care and outcome at very preterm
birth (RP-PG- 0609-10107).
2In philosophical work this is sometimes arrived at
using a mind-map technique.
3As Additional file 4 shows only 3 studies included
questions about hypothetical scenarios as opposed to ac-
tual consent processes, and 2 of these were with clini-
cians not parents.
4Scare quotes are used here as, to the extent the par-
ents are deciding whether or not to enter their child, it
is not directly altruism on their behalf, since the child is
the one entering the trial, not the parents. Of course in
some cases, as in cord-clamping trials, it might be both
mother and child that enter the trial. As will be dis-
cussed later, one gap in the empirical literature was
study of cases of maternal-fetal research.
5We follow the convention of referring to the baby as
‘him’ (using the ungendered form) to distinguish the
baby from the mother in what follows.
6Additional file 3 gives additional findings for this sec-
tion and for further sections.
7More recently Nathan found – using a competence as-
sessment tool – that parents of sick neonates gave signifi-
cantly more valid consent than patients with Alzheimer’s
or schizophrenia, though comparison with previously
Wilman et al. Trials  (2015) 16:502 Page 11 of 13published control groups using the same assessment tool
gave variable results [58]. But this does not necessarily
show that their consent was valid.
8Voluntariness, informedness and competence (rational-
ity) are the three standard criteria for informed consent.
9The authors raise the question of whether the initial
consent is really ‘permission to be approached later’ and
the ‘actual consent’ for the study then takes place at the
second discussion.
10Full tabulated results are presented in Additional file 1.
11Though not all the reasons are good ones. The con-
sent process might be seen as having a very small role in
protecting neonates from risk, but the main responsibil-
ity for that lies with research designers and research eth-
ics committees which are much better placed than most
lay parents to make such judgements of risk. This is
pretty clear on philosophical grounds alone, but one
piece of data in the studies (about parental assessment
of risks) also supports this.
12It might be suggested that with respect to these sec-
ond and third claims the force of an appeal to empirical
data alone is less compelling. This is because, although
parental claims about how comfortable they felt in a
consent process are of interest, it is very likely that par-
ents in general will not have thought through the criteria
for valid informed consent, so not appreciate fully the
challenges to providing genuinely valid informed consent
in certain neonatal research contexts. So even where a
parent reports ‘comfort’ with a consent process this is
not sufficient to show that such a process was a satisfac-
tory means of gaining valid consent.
13Allmark’s suggestion is similar to this, but his version
is expressed in terms of continuous consent [46].
14A review by Claire Snowden et al. on the BRACE-
LET research has now reported on views of bereaved
parents, but this research was published after the our re-
view was completed. A reviewer notes that they were
also considered by Allmark and Mason [46].
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